Nancy L. Sheehan

742 total citations
34 papers, 518 citations indexed

About

Nancy L. Sheehan is a scholar working on Infectious Diseases, Virology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Nancy L. Sheehan has authored 34 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 9 papers in Virology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Nancy L. Sheehan's work include HIV/AIDS drug development and treatment (16 papers), HIV/AIDS Research and Interventions (13 papers) and HIV Research and Treatment (9 papers). Nancy L. Sheehan is often cited by papers focused on HIV/AIDS drug development and treatment (16 papers), HIV/AIDS Research and Interventions (13 papers) and HIV Research and Treatment (9 papers). Nancy L. Sheehan collaborates with scholars based in Canada, United States and Netherlands. Nancy L. Sheehan's co-authors include Cara Tannenbaum, Alice Tseng, Niamh Higgins, Marie‐Josée Brouillette, Jacques Turgeon, C. J. L. la Porte, Thierry Hurlimann, Nathalie Letarte, Jean‐Philippe Lambert and Laura Robb and has published in prestigious journals such as Molecules, AIDS and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Nancy L. Sheehan

29 papers receiving 498 citations

Peers

Countries citing papers authored by Nancy L. Sheehan

Since Specialization

Citations

This map shows the geographic impact of Nancy L. Sheehan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy L. Sheehan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy L. Sheehan more than expected).

Fields of papers citing papers by Nancy L. Sheehan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy L. Sheehan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy L. Sheehan. The network helps show where Nancy L. Sheehan may publish in the future.

Co-authorship network of co-authors of Nancy L. Sheehan

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy L. Sheehan. A scholar is included among the top collaborators of Nancy L. Sheehan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy L. Sheehan. Nancy L. Sheehan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CHANGE-Rx: frailty, falls, polypharmacy, and inappropriate medication use in a Canadian cohort of people aged 65 years and older with HIV 2025 ·AIDS ·(unknown), Alice Tseng, Nancy L. Sheehan, Sharon Walmsley, Julian Falutz, (unknown)	0
2	Prevalence of medication overload among older people with HIV: a MedSafer study 2024 ·BMC Infectious Diseases ·Émilie Bortolussi‐Courval, Elizabeth Smyth, Cecilia T. Costiniuk, Julian Falutz, (unknown), Kathy Liu, (unknown), Nancy L. Sheehan, Todd C. Lee, Emily G. McDonald	2
3	Pharmacotherapeutic Interventions in People Living With HIV Undergoing Solid Organ Transplantation: A Scoping Review 2023 ·Transplantation Direct ·Cindy Lo Kuen Lam, Sébastien Landry, (unknown), (unknown), (unknown), (unknown), Dominic Martel, Anne Julie Frenette, (unknown), Danielle Rouleau, Marcelo Cantarovich, Marina B. Klein, Nancy L. Sheehan, (unknown)	0
4	Camu Camu effects on microbial translocation and systemic immune activation in ART-treated people living with HIV: protocol of the single-arm non-randomised Camu Camu prebiotic pilot study (CIHR/CTN PT032) 2022 ·BMJ Open ·Stéphane Isnard, Brandon Fombuena, Jing Ouyang, Léna Royston, John Lin, (unknown), Nancy L. Sheehan, Péter L. Lakatos, Talat Bessissow, Nicolas Chomont, Marina B. Klein, Bertrand Lebouché, Cecilia T. Costiniuk, Bertrand Routy, André Marette, Jean‐Pierre Routy	4
5	Remdesivir in Patients With Severe Kidney Dysfunction 2022 ·JAMA Network Open ·Matthew P. Cheng, Rob Fowler, Srinivas Murthy, Ruxandra Pinto, Nancy L. Sheehan, Alice Tseng	17
6	Use and safety of appearance and performance enhancing supplements in gay, bisexual, and other men who have sex with men receiving daily tenofovir disoproxil fumarate/emtricitabine as HIV pre-exposure prophylaxis 2022 ·AIDS Care ·(unknown), Alice Tseng, Nancy L. Sheehan, Isaac I. Bogoch	1
7	Understanding the Risks and Benefits of a Patient Portal Configured for HIV Care: Patient and Healthcare Professional Perspectives 2022 ·Journal of Personalized Medicine ·(unknown), David Lessard, Moustafa Laymouna, Kim Engler, Tibor Schuster, Yuanchao Ma, Nadine Kronfli, Jean‐Pierre Routy, Tarek Hijal, Karine Lacombe, Nancy L. Sheehan, Hayette Rougier, Bertrand Lebouché	3
8	Relationship between raltegravir trough plasma concentration and virologic response and the impact of therapeutic drug monitoring during pregnancy 2022 ·International Journal of STD & AIDS ·(unknown), Nancy L. Sheehan, (unknown), Fatima Kakkar, Marc Boucher, Ema Ferreira, Isabelle Boucoiran	2
9	Predictive Factors of Detectable Viral Load in HIV-Infected Patients 2021 ·AIDS Research and Human Retroviruses ·(unknown), (unknown), (unknown), (unknown), Nancy L. Sheehan, Mireille E. Schnitzer, Guanbo Wang, (unknown), (unknown)	7
10	Delayed linkage to HIV care among asylum seekers in Quebec, Canada 2019 ·BMC Public Health ·Nadine Kronfli, (unknown), Nancy L. Sheehan, Joseph Cox, Isabelle Hardy, Bertrand Lebouché, Alexandra de Pokomandy, Charles Frenette, Michel Roger, Marina B. Klein	17
11	Therapeutic drug monitoring in treatment-experienced HIV-infected patients receiving darunavir-based salvage regimens: A case series 2018 ·Antiviral Research ·Sébastien Landry, (unknown), Nimish Patel, Alice Tseng, Richard Lalonde, (unknown), Steven Sanche, Nancy L. Sheehan	4
12	Antiretroviral drug transporters and metabolic enzymes in human testicular tissue: potential contribution to HIV-1 sanctuary site 2016 ·Journal of Antimicrobial Chemotherapy ·(unknown), Md. Tozammel Hoque, Mohammad‐Ali Jenabian, Kishanda Vyboh, (unknown), Nancy L. Sheehan, P. Brassard, (unknown), Nicolas Chomont, Courtney V. Fletcher, Jean‐Pierre Routy, Reina Bendayan	48
13	Understanding and preventing drug–drug and drug–gene interactions 2014 ·Expert Review of Clinical Pharmacology ·Cara Tannenbaum, Nancy L. Sheehan	110
14	Citalopram for the Prevention of Depression and Its Consequences in HIV-Hepatitis C Coinfected Individuals Initiating Pegylated Interferon/Ribavirin Therapy: A Multicenter Randomized Double-Blind Placebo-Controlled Trial 2014 ·HIV Clinical Trials ·Marina B. Klein, Terry Lee, Marie‐Josée Brouillette, Nancy L. Sheehan, Sharon Walmsley, David Wong, Brian Conway, Mark Hull, Curtis Cooper, (unknown), Sylvie Vézina, L Annable, Simon N. Young, (unknown), Joel Singer, (unknown)	6
15	Negligible Effect of Tenofovir on Atazanavir Trough Concentrations and Genotypic Inhibitory Quotients in the Presence and Absence of Ritonavir 2013 ·Therapeutic Drug Monitoring ·(unknown), Niamh Higgins, Réjean Thomas, Jean-Guy Baril, (unknown), Richard Lalonde, Nancy L. Sheehan	7
16	Role of the Pharmacist in Caring for Patients with HIV/AIDS: Clinical Practice Guidelines 2012 ·The Canadian Journal of Hospital Pharmacy ·Alice Tseng, Michelle Foisy, Christine Hughes, Deborah Kelly, (unknown), Natalie Dayneka, Pierre Giguère, Niamh Higgins, (unknown), (unknown), C. J. L. la Porte, (unknown), Laura Park‐Wyllie, (unknown), Linda Robinson, Nancy L. Sheehan, Shannon Stone, (unknown), Deborah Yoong	51
17	The Effect of β-Carotene Supplementation on the Pharmacokinetics of Nelfinavir and Its Active Metabolite M8 in HIV-1-infected Patients 2012 ·Molecules ·Nancy L. Sheehan, Rolf P. G. van Heeswijk, Brian C. Foster, Humayoun Akhtar, Neera Singhal, Isabelle Seguin, (unknown), (unknown), (unknown), (unknown), David M. Burger, Richard Lalonde, D. William Cameron	13
18	Antiretroviral Therapeutic Drug Monitoring in Canada: Current Status and Recommendations for Clinical Practice 2009 ·The Canadian Journal of Hospital Pharmacy ·Niamh Higgins, Alice Tseng, Nancy L. Sheehan, C. J. L. la Porte	23
19	CTN-194 (PICCO): Design of a trial of citalopram for the prevention of depression and its consequences in HIV-Hepatitis C co-infected individuals initiating pegylated interferon/ribavirin therapy 2008 ·Contemporary Clinical Trials ·Marina B. Klein, Curtis Cooper, Marie‐Josée Brouillette, Nancy L. Sheehan, Chawki Benkelfat, L Annable, (unknown), (unknown), Joel Singer	9
20	Experiences of mental health discrimination in New Zealand 2006 ·Health & Social Care in the Community ·(unknown), (unknown), Nancy L. Sheehan, (unknown)	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact